Allspring Global Investments Holdings, LLC Poseida Therapeutics, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 34 shares of PSTX stock, worth $323. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34Holding current value
$323% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding PSTX
# of Institutions
103Shares Held
38.7MCall Options Held
377KPut Options Held
22.2K-
Pentwater Capital Management LP Naples, FL5.98MShares$56.8 Million0.18% of portfolio
-
Black Rock Inc. New York, NY4.91MShares$46.6 Million0.0% of portfolio
-
Silverarc Capital Management, LLC3.69MShares$35 Million2.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.66MShares$34.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.19MShares$20.8 Million0.0% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $815M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...